Literature DB >> 18460912

Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis.

Dennis E Vance1.   

Abstract

PURPOSE OF REVIEW: This review summarizes the role of phosphatidylcholine metabolism in plasma lipoprotein homeostasis. RECENT
FINDINGS: While it was previously known that phosphatidylcholine biosynthesis was required for normal hepatic VLDL secretion, recent studies have shown that both phosphatidylcholine biosynthetic pathways (the cytidine 5'-diphosphocholine and the phosphatidylethanolamine methylation pathways) are required. In addition, a requirement of acyl-coenzyme A synthetase 3, but not acyl-coenzyme A synthetase 1 or 4, for phosphatidylcholine synthesis and VLDL secretion is now documented. ABCA1 has been implicated in the transfer of phosphatidylcholine to apolipoproteinA-1 both during and after secretion of apolipoproteinA-1. Other studies have introduced the concept of reverse phosphatidylcholine transport in which both HDL and LDL supply phosphatidylcholine to the liver. An unexpected finding is that half of the phosphatidylcholine delivered to liver from lipoproteins is converted into triacylglycerol.
SUMMARY: The liver is both a donor of phosphatidylcholine during the assembly and secretion of lipoproteins as well as a recipient of phosphatidylcholine from plasma lipoproteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18460912     DOI: 10.1097/MOL.0b013e3282fee935

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  47 in total

Review 1.  Hepatic ABCA1 and VLDL triglyceride production.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta       Date:  2011-10-06

Review 2.  Genome-based nutrition: an intervention strategy for the prevention and treatment of obesity and nonalcoholic steatohepatitis.

Authors:  Sonia Roman; Claudia Ojeda-Granados; Omar Ramos-Lopez; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 3.  The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications.

Authors:  Jason R Goldsmith; R Balfour Sartor
Journal:  J Gastroenterol       Date:  2014-03-21       Impact factor: 7.527

4.  Lipoprotein particles of intraocular origin in human Bruch membrane: an unusual lipid profile.

Authors:  Lan Wang; Chuan-Ming Li; Martin Rudolf; Olga V Belyaeva; Byung Hong Chung; Jeffrey D Messinger; Natalia Y Kedishvili; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-20       Impact factor: 4.799

Review 5.  Choline and betaine in health and disease.

Authors:  Per Magne Ueland
Journal:  J Inherit Metab Dis       Date:  2010-05-06       Impact factor: 4.982

6.  The Lysophosphatidylcholine Transporter MFSD2A Is Essential for CD8+ Memory T Cell Maintenance and Secondary Response to Infection.

Authors:  Ann R Piccirillo; Eric J Hyzny; Lisa Y Beppu; Ashley V Menk; Callen T Wallace; William F Hawse; Heather M Buechel; Bernice H Wong; Juat Chin Foo; Amaury Cazenave-Gassiot; Markus R Wenk; Greg M Delgoffe; Simon C Watkins; David L Silver; Louise M D'Cruz
Journal:  J Immunol       Date:  2019-05-24       Impact factor: 5.422

7.  Hepatic Steatosis Accompanies Pulmonary Alveolar Proteinosis.

Authors:  Alan N Hunt; Anagha Malur; Tual Monfort; Pavlos Lagoudakis; Sumeet Mahajan; Anthony D Postle; Mary Jane Thomassen
Journal:  Am J Respir Cell Mol Biol       Date:  2017-10       Impact factor: 6.914

Review 8.  Liver X receptors in lipid signalling and membrane homeostasis.

Authors:  Bo Wang; Peter Tontonoz
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

9.  The development of a metabolic disease phenotype in CTP:phosphoethanolamine cytidylyltransferase-deficient mice.

Authors:  Morgan D Fullerton; Fatima Hakimuddin; Arend Bonen; Marica Bakovic
Journal:  J Biol Chem       Date:  2009-07-22       Impact factor: 5.157

Review 10.  Breath volatile organic compounds for the gut-fatty liver axis: promise, peril, and path forward.

Authors:  Steven Francis Solga
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.